Exact Mass: 309.0783

Exact Mass Matches: 309.0783

Found 12 metabolites which its exact mass value is equals to given mass value 309.0783, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Glymidine

N-[5-(2-methoxyethoxy)-2-pyrimidinyl]benzenesulphonamide

C13H15N3O4S (309.0783)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BC - Sulfonamides (heterocyclic) C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

   

Glycodiazine

N-[5-(2-Methoxyethoxy)pyrimidin-2-yl]benzenesulphonamide

C13H15N3O4S (309.0783)


Glycodiazine is used with diet to lower blood glucose by increasing the secretion of insulin from pancreas and increasing the sensitivity of peripheral tissues to insulin. The mechanism of action of glycodiazine in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glycodiazine likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. It is used for the concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BC - Sulfonamides (heterocyclic) C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

   

N(4)-Acetylsulfisoxazole

N-{4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulphamoyl]phenyl}ethanimidic acid

C13H15N3O4S (309.0783)


D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   
   
   

(4-((2-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)PHENYL)BORONIC ACID

(4-((2-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)PHENYL)BORONIC ACID

C14H11BF3NO3 (309.0784)


   

3-(3H-imidazol-4-yl)-2-[(4-methylphenyl)sulfonylamino]propanoic acid

3-(3H-imidazol-4-yl)-2-[(4-methylphenyl)sulfonylamino]propanoic acid

C13H15N3O4S (309.0783)


   

Sulfisoxazole Acetyl

sulfisoxazole acetyl (200 mg)

C13H15N3O4S (309.0783)


C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

(3-((3-(trifluoromethyl)phenyl)carbamoyl)phenyl)boronic acid

(3-((3-(trifluoromethyl)phenyl)carbamoyl)phenyl)boronic acid

C14H11BF3NO3 (309.0784)


   

(2,3,4,5,6-pentafluorophenyl) 1-methylpiperidine-3-carboxylate

(2,3,4,5,6-pentafluorophenyl) 1-methylpiperidine-3-carboxylate

C13H12F5NO2 (309.0788)


   

5-(4-methylpiperazin-1-yl)sulfonyl-1H-indole-2,3-dione

5-(4-methylpiperazin-1-yl)sulfonyl-1H-indole-2,3-dione

C13H15N3O4S (309.0783)


   

N-[5-(3,4-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamic acid ethyl ester

N-[5-(3,4-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamic acid ethyl ester

C13H15N3O4S (309.0783)